ZeroStack Corp.
ZSTKNasdaq
$1.65
↓ -2.9%Jul 20 close · end-of-day
Price
1Y↓ -86.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$16,928.60
Enterprise Value
$1.2M
P/E
—
P/S
0.0
P/B
0.0
EV/EBITDA
—
PEG
—
FCF Yield
-58864.9%
Dividend Yield
—
Revenue (TTM)
$36.1M
Net Income (TTM)
—
Free Cash Flow (TTM)
-$10.0M
Gross Margin
11.8%
Operating Margin
-597.7%
Net Margin
—
ROE
—
ROIC
-448.7%
Debt / Equity
0.1
Net Cash
-$1.2M
Return 1Y
—
Company profile
Flora Growth Corp., a cannabis company, cultivates, processes, and supplies cannabis products to pharmacies, medical clinics, and cosmetic companies. The company's brand includes Mambe, Mind Naturals, Almost Virgin, Flora Lab, and Stardog Loungewear. It also manufactures and sells hemp textiles products focuses on servicing the hospitality, medical, and clothing industries.
- CEO
- Luis Merchan
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 280
- Headquarters
- Florida
- Website
- floragrowth.com
Earnings
ZSTK Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$7.3M↑ +5.9%
Diluted EPS-$3.68↑ +139.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $9.0M | $33.4M | $76.1M | $35.9M | $35.7M |
| Gross profit | $2.4M | $13.3M | $17.7M | $2.2M | $1.6M |
| Operating income | -$19.0M | -$47.2M | -$50.4M | -$8.9M | -$154.7M |
| Net income | -$21.4M | -$52.4M | -$57.0M | -$15.9M | — |
| Diluted EPS | — | -$13.68 | -$7.75 | -$50.02 | -$43.49 |
| Operating cash flow | -$20.9M | -$15.9M | -$8.4M | -$5.0M | -$8.7M |
| Free cash flow | -$24.9M | -$17.2M | -$8.6M | -$5.2M | -$8.8M |
| Gross margin | 27.0% | 39.7% | 23.3% | 6.1% | 4.6% |
| Operating margin | -211.6% | -141.4% | -66.2% | -24.9% | -433.5% |
| Net margin | -237.9% | -156.9% | -75.0% | -44.4% | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.7M | $7.2M | -$5.1M | $6.9M | $14.8M | $9.7M | $4.3M | $7.3M |
| Gross profit | $3.2M | $495,000.00 | -$5.3M | $535,000.00 | $2.8M | $335,000.00 | -$2.1M | $3.1M |
| Operating income | -$3.5M | -$2.1M | -$786,000.00 | -$1.6M | -$2.6M | -$3.3M | -$147.2M | -$62.7M |
| Net income | -$2.6M | -$3.8M | -$6.1M | — | -$2.4M | -$6.7M | — | — |
| Diluted EPS | -$0.21 | -$11.03 | -$38.40 | -$1.54 | -$0.11 | -$9.05 | -$32.79 | -$3.68 |
| Operating cash flow | -$265,000.00 | -$2.1M | -$1.3M | -$2.7M | -$3.0M | $100,000.00 | -$3.2M | -$3.8M |
| Free cash flow | -$291,000.00 | -$2.1M | -$1.3M | -$2.7M | -$3.0M | $91,000.00 | -$3.2M | -$3.8M |
| Gross margin | 20.2% | 6.8% | 104.6% | 7.8% | 19.1% | 3.4% | -48.1% | 43.2% |
| Operating margin | -22.6% | -29.2% | 15.5% | -23.6% | -17.3% | -33.5% | -3450.6% | -861.3% |
| Net margin | -16.8% | -52.1% | 120.5% | — | -16.3% | -68.3% | — | — |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.